New diabetes clinical trial: Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes

Published on: December 01, 2024 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM); Obesity Type 2 Diabetes Mellitus
Interventions: Biological: PG-102; Other: Placebo
Sponsors: ProGen. Co., Ltd.
Not yet recruiting
https://ift.tt/1OkBvDS